Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
584 |
4. Check minimum number of eventsNone |
584 |
5. Include endpointsNone |
584 |
6. Filter based on genotype QC (FinnGen only) |
584 |
Control definitions (FinnGen only)
- Control exclude
- G6_MYONEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G70
Similar endpoints
↥List of similar endpoints to
Myasthenia gravis
based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3518 | 1791 | 1681 |
| Only index persons | 2942 | 1550 | 1392 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 56.01 | 50.07 | 62.40 |
| Only index persons | 54.55 | 48.24 | 61.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 584 | 311 | 273 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.12 |
| Median age at first event (years) | 54.73 | 47.39 | 63.10 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 525
- Matched controls
- 5252
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N07AA02
ATC
pyridostigmine; systemic
6685.3
323.0
420
*
108
Kela drug reimbursment
Myasthenia gravis
+∞
323.0
382
*
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
323.0
484
*
L04AX01
ATC
azathioprine; systemic
34.2
139.4
185
82
H53.2
ICD-10 Finland
Diplopia
30.3
97.9
133
58
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
+∞
90.3
84
*
H02.4
ICD-10 Finland
Ptosis of eyelid
24.5
86.4
125
66
N07AA03
ATC
distigmine; systemic
309.1
79.9
79
*
G70.9
ICD-10 Finland
Myoneural disorder, unspecified
+∞
78.1
73
*
R03CA02
ATC
ephedrine; oral
300.7
54.2
54
*
3580A
ICD-9 Finland
Myoneural disorders, Myasthenia gravis
+∞
53.0
50
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.0
49.7
105
128
A12BA01
ATC
potassium chloride; oral
12.2
47.3
89
86
73300
ICD-8 Finland
Other diseases of muscle, tendon and fascia, Myasthenia gravis
+∞
42.3
40
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.1
39.1
116
232
H02AB06
ATC
prednisolone; systemic
3.3
36.3
335
1841
G70
ICD-10 Finland
Myasthenia gravis and other myoneural disorders
+∞
33.7
32
*
N99
ICPC
Neurological disease other
32.5
32.2
42
14
R13
ICD-10 Finland
Dysphagia
6.8
30.9
82
139
5872
FHL
Thymic exploration or thymectomy
+∞
30.5
29
*
GEC23
NOMESCO Finland
Transsternal thymectomy
308.1
29.1
29
*
GD1AD
NOMESCO Finland
Thorax CT examination
7.4
27.1
67
102
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
24.9
297
1736
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
23.1
22
*
2AB04
NOMESCO Finland
NA
109.2
19.7
21
*
H02AB07
ATC
prednisone; oral
3.0
18.8
121
472
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
18.7
125
497
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
18.3
75
204
G35
ICD-10 Finland
Multiple sclerosis
12.5
18.0
32
27
H50.2
ICD-10 Finland
Vertical strabismus
23.8
17.9
25
11
G70.28
ICD-10 Finland
Other congenital and developmental myasthenia
+∞
17.8
17
*
GEC26
NOMESCO Finland
Mediastinoscopic thymectomy
+∞
17.8
17
*
AA1AD
NOMESCO Finland
CT of head and brain
2.5
17.5
162
782
R4130
NOMESCO Finland
Speech therapy
9.7
16.9
34
37
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
16.9
202
1109
WW400
NOMESCO Finland
Plasmaferesis
65.5
16.8
19
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
16.2
69
194
ZXC96
NOMESCO Finland
Robot assisted procedure
7.7
16.0
37
51
R47.1
ICD-10 Finland
Dysarthria and anarthria
17.9
15.7
24
14
G70.8
ICD-10 Finland
Other specified myoneural disorders
+∞
15.7
15
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
15.1
56
139
G70.20
ICD-10 Finland
Congenital and developmental myasthenia
+∞
14.6
14
*
A02BC02
ATC
pantoprazole; systemic
2.0
13.3
359
2696
G70.1
ICD-10 Finland
Toxic myoneural disorders
+∞
12.5
12
*
N28
ICPC
Limited function/disability (N)
10.9
12.4
23
22
G70.21
ICD-10 Finland
Limb girdle myasthenia
+∞
11.5
11
*
R4110
NOMESCO Finland
Physiotherapy
2.0
10.9
159
920
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
16.4
10.4
16
10
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
17.9
9.4
14
8
73308
ICD-8 Finland
NA
+∞
9.4
9
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
9.1
76
338
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
15.9
9.1
14
9
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.6
109
590
G73.1*C80.99
ICD-10 Finland
Eaton-Lambert syndrome
+∞
8.4
8
*
XA100
NOMESCO Finland
Tensilon test
+∞
8.4
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.8
8.2
26
56
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
8.1
74
341
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
11.9
8.1
14
12
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
10.3
8.1
15
15
L28
ICPC
Limited function/disability (L)
2.2
8.0
89
451
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.3
7.8
38
121
N29
ICPC
Neurological sympt/complt other
6.1
7.8
20
34
ZX120
NOMESCO Finland
Intravenous
2.4
7.6
66
299
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
81.2
7.4
8
*
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
81.2
7.4
8
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
7.4
95
513
R06.0
ICD-10 Finland
Dyspnoea
1.8
7.4
141
881
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
9.6
7.3
14
15
G72.8
ICD-10 Finland
Other specified myopathies
+∞
7.3
7
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
7.2
95
521
R1260
NOMESCO Finland
Evaluation of communicative skills
6.2
7.1
18
30
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
6.9
204
1451
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
6.8
34
111
6BA02
NOMESCO Finland
NA
22.8
6.7
9
*
TAB00
NOMESCO Finland
Lumbar puncture
3.1
6.7
35
119
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
6.6
191
1343
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.2
6.6
23
56
Z3231
NOMESCO Finland
Registered nurse
1.7
6.5
144
937
XKC03
NOMESCO Finland
Water cystometry
3.9
6.5
25
67
CE2W4
NOMESCO Finland
Eye movement mapping
70.7
6.4
7
*
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
11.2
6.3
11
10
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
6.3
202
1460
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
6.3
6
*
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
6.1
64
318
XCK00
NOMESCO Finland
Perimetry
2.6
6.0
43
177
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
223
34
105.49
307.65
1.3
1.1
nmol/l
11.6
0.1
—
149
5
(42870588) Differential panel, method unspecified - Blood
325
1578
3.39
46.29
12.9
5.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
308
1466
3.33
45.00
2.9
2.0
u/l
153.7
152.0
0.03
300
1383
(3006315) Basophils [#/volume] in Blood
400
2382
3.16
37.01
13.9
5.6
e9/l
0.0
0.0
0.89
366
2070
(3001604) Monocytes [#/volume] in Blood
399
2373
3.15
36.99
13.8
5.6
e9/l
0.6
0.6
0.19
365
2057
(3019198) Lymphocytes [#/volume] in Blood
400
2426
3.06
34.95
14.0
5.6
e9/l
1.6
2.0
4.62
368
2150
(3013115) Eosinophils [#/volume] in Blood
403
2461
3.06
34.64
14.2
5.9
e9/l
0.2
0.2
2.47
370
2177
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
46
9.26
32.26
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
43
9.38
31.01
1.2
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
389
2424
2.81
30.46
8.1
7.0
mmol/l
1.2
1.2
0.47
342
2066
(3005719) IgG [Mass/volume] in Serum or Plasma
113
361
3.64
30.00
2.5
2.6
g/l
9.3
10.6
2.13
107
331
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
366
2223
2.73
29.95
7.3
6.0
mmol/l
1.2
1.2
0.30
352
2013
(3013650) Neutrophils [#/volume] in Blood by Automated count
420
2789
2.80
27.86
16.4
9.1
e9/l
4.3
4.1
0.94
388
2451
(3012095) Magnesium [Moles/volume] in Serum or Plasma
177
787
2.79
26.46
3.2
3.4
mmol/l
0.8
0.8
0.29
172
741
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
19
10
19.61
24.02
1.2
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
34
46
7.79
23.99
3.3
1.8
e9/l
1.1
1.1
0.07
17
24
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
31
9.08
21.69
3.0
1.8
%
15.8
12.3
—
10
20
(3013826) Glucose [Moles/volume] in Serum or Plasma
405
2849
2.38
20.41
7.0
4.8
mmol/l
6.6
6.7
0.94
393
2672
(21494814) CD8 cells/100 lymphocytes in Specimen
17
10
17.48
20.36
1.8
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
30
43
7.30
20.11
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
32
51
6.58
19.47
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
179
916
2.38
19.09
1.7
1.5
g/l
2.1
2.5
1.98
131
565
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
23
9.90
18.88
1.1
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
48
115
4.46
18.72
1.4
1.4
mg/l
504.6
463.2
0.39
48
106
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
30
48
6.53
18.18
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
27
40
7.03
17.55
3.3
1.9
e6/l
799.4
831.2
0.05
14
15
(21494815) CD4 cells/100 lymphocytes in Specimen
25
36
7.21
16.66
2.2
1.8
%
53.7
32.4
—
7
5
(3018418) pH of Serum or Plasma
241
1468
2.09
16.21
4.1
4.1
ph
7.4
7.4
0.18
37
268
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
13
12.63
16.08
1.2
1.0
miu/ml
1830.8
1430.5
0.52
16
13
(3016502) Oxygen saturation in Arterial blood
116
524
2.51
16.00
9.1
7.8
%
95.9
95.7
0.11
111
504
(4027681)
20
23
8.97
15.98
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
123
579
2.42
15.49
8.9
7.5
mmol/l
1.8
1.3
0.89
99
448
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
122
583
2.38
14.80
9.0
7.4
kpa
5.3
5.1
2.21
114
559
(3027801) Oxygen [Partial pressure] in Arterial blood
122
583
2.38
14.80
9.0
7.4
kpa
12.1
12.1
0.03
115
561
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
26
7.93
14.50
1.1
1.0
u/l
1.0
1.1
—
9
16
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
287
2.85
14.30
4.8
4.1
mmol/l
1.5
1.7
0.26
69
214
(3036481) Cortisol [Moles/volume] in Serum or Plasma
100
443
2.52
14.28
2.0
2.0
nmol/l
351.0
375.3
0.60
95
414
(3009343) pH of Capillary blood
77
300
2.80
14.20
4.9
4.1
ph
7.4
7.4
—
8
38
(3033658) Prothrombin time (PT) actual/Normal
199
1183
2.03
13.85
4.9
3.8
%
93.3
90.0
1.24
193
1154
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
102
4.03
13.55
1.5
1.3
e6/l
2.8
11.8
0.70
32
77
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
102
4.03
13.55
1.6
1.4
e6/l
111.0
1228.7
0.51
32
80
(3044290) Cell count panel - Cerebral spinal fluid
36
89
4.24
13.47
1.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
62
223
2.99
13.20
5.0
4.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
15
10.24
13.18
3.2
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
301
2087
1.91
13.16
4.6
4.9
g/l
34.7
35.5
1.53
285
1947
(40758558) Short blood count panel - Blood
198
1196
1.99
13.03
11.0
7.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
25
48
5.40
12.59
1.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
290
2010
1.88
12.47
7.3
8.9
inr
1.3
1.2
0.19
58
581
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
454
3653
2.09
12.36
4.5
3.8
pmol/l
15.0
14.8
0.95
439
3282
(3000991) Gas panel - Venous blood
89
402
2.43
12.11
9.5
8.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
93
429
2.39
12.08
8.8
6.8
mmol/l
1.3
1.3
0.05
88
408
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
334
2.50
11.41
1.6
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
116
603
2.15
11.29
1.4
1.3
titre
433.5
479.1
0.23
37
135
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
31
6.30
11.26
3.4
1.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
18
29
6.37
10.79
1.0
1.2
u/l
5.0
6.8
0.52
13
24
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
187
1179
1.86
10.42
2.9
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
75
335
2.42
10.41
6.5
4.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
294
2124
1.77
10.39
16.8
9.6
e9/l
0.0
0.0
0.05
241
1750
(3013707) Erythrocyte sedimentation rate by Westergren method
441
3597
1.92
10.37
4.9
4.1
mm/h
11.9
12.4
0.24
421
3301
(3052851) Hemolysis interference index of Serum or Plasma
41
134
3.22
10.26
3.7
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
510
4394
2.27
10.10
6.0
4.6
mu/l
1.9
2.2
0.53
493
3974
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
142
3.11
9.94
1.6
1.5
iu/ml
1.0
0.0
—
6
31
(3016018) Differential panel - Cerebral spinal fluid
20
39
5.27
9.90
1.8
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
116
638
2.02
9.61
4.3
5.9
mmol/l
1.0
1.0
0.14
107
581
(3044640) Blood type and Crossmatch panel - Blood
226
1547
1.75
9.37
3.4
2.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
61
260
2.50
9.35
10.7
9.5
mmol/l
25.3
24.7
1.04
56
244
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
262
2.48
9.20
11.0
9.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
73
341
2.30
9.14
1.6
2.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
135
799
1.90
8.99
2.0
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
276
2018
1.70
8.88
2.3
2.0
pmol/l
92.9
94.3
0.19
162
1040
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
251
1789
1.71
8.88
4.8
3.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
42
152
2.90
8.84
2.0
1.4
g/l
0.2
0.2
1.57
42
145
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
153
2.88
8.74
2.1
1.9
—
—
—
0
0
(3036489) Thrombin time
44
165
2.80
8.69
1.7
2.4
s
21.9
21.5
0.14
39
151
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
172
2.75
8.57
1.8
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
76
3.68
8.50
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
66
305
2.31
8.47
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
91
482
2.05
8.30
4.3
4.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
196
1325
1.72
8.29
4.3
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
125
3.00
8.16
1.2
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
5
22.38
8.04
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
11
5
22.38
8.04
1.0
1.0
mg/g
6.6
6.5
—
11
5
(3018095) Leukocytes [#/volume] in Urine
240
1730
1.66
7.89
5.4
3.7
e6/l
43.7
93.4
1.15
185
1245
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
264
1950
1.65
7.88
2.4
2.3
nmol/l
74.8
76.6
0.50
242
1719
(3002582) Erythrocytes [#/volume] in Urine
214
1498
1.68
7.87
4.5
3.1
e6/l
44.6
99.4
0.59
178
1166
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
22
6.02
7.41
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
444
3774
1.74
7.39
9.2
7.6
u/l
75.6
78.7
0.73
429
3529
(3031040) Bacteria [#/volume] in Urine by Automated count
390
3210
1.65
7.28
6.9
4.4
e6/l
1713.9
1042.6
—
8
56
(3037467) Urinalysis macro (dipstick) panel - Urine
402
3335
1.66
7.26
6.0
4.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
31
106
3.03
7.23
2.6
3.5
umol/l
29.1
34.3
0.92
26
88
(46235355) HIV 1 and 2 tests - Meaningful Use set
118
714
1.82
7.20
1.4
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1538
1.63
7.11
3.3
3.4
u/l
32.1
30.7
0.26
207
1466
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1472
1.63
6.98
3.3
3.1
ng/l
1409.6
1279.9
0.19
176
1259
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
191
2.47
6.98
1.3
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
191
2.47
6.98
1.3
2.4
g/l
7.2
7.4
0.36
37
140
(3024869) Neuronal Ab [Presence] in Serum
11
8
13.98
6.91
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
142
919
1.72
6.85
5.0
3.8
ng/l
71.9
226.2
1.97
115
722
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
255
1914
1.59
6.84
5.1
3.8
ng/l
209.0
37.8
0.46
197
1380
(3023368) Bacteria identified in Blood by Culture
192
1346
1.64
6.83
4.7
4.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
158
1055
1.68
6.79
3.1
2.5
e6/l
5.5
5.9
0.13
143
929
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
159
1064
1.68
6.77
1.8
1.8
mg/l
1.5
1.2
0.59
126
815
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
286
2.18
6.76
1.8
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
14
7.25
6.71
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
14
7.25
6.71
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
14
7.25
6.71
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
189
2.44
6.66
1.9
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
148
979
1.69
6.56
3.2
2.8
mosm/kgh2o
556.9
561.4
0.10
131
833
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
178
2.46
6.54
1.3
2.4
g/l
3.2
3.2
0.08
35
136
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
191
2.41
6.51
1.3
2.4
g/l
3.5
3.7
0.34
32
134
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
14
29
4.92
6.48
1.4
1.2
mmol/l
2.2
1.8
0.34
14
29
(3039162) Centromere protein B Ab [Units/volume] in Serum
22
65
3.48
6.48
1.2
1.2
—
75.1
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
114
2.82
6.38
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
22
5.55
6.31
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
99
591
1.81
6.27
1.3
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
225
1671
1.56
6.15
3.1
3.5
mmol/l
2.3
2.4
3.39
197
1461
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
176
1236
1.61
6.11
2.5
2.1
mg/l
3.0
3.1
0.20
155
1041
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
27
95
2.93
6.02
1.4
1.2
u/ml
73.9
34.3
—
6
9
(3012544) pH of Venous blood
83
475
1.87
6.01
3.9
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
191
1377
1.58
5.90
4.5
3.0
e6/l
0.5
0.5
0.04
155
1038
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
24
5.08
5.76
1.1
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
29
109
2.75
5.75
1.1
1.2
—
8.6
—
0
10
(3019550) Sodium [Moles/volume] in Serum or Plasma
540
4978
2.13
5.63
26.5
16.8
mmol/l
139.8
139.7
0.66
533
4844
(3023103) Potassium [Moles/volume] in Serum or Plasma
541
4992
2.14
5.60
28.1
16.9
mmol/l
4.0
4.0
1.08
536
4850
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
21
5.32
5.54
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
90
2.86
5.37
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
90
2.86
5.37
1.6
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
48
3.62
5.36
1.5
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
18
53
3.47
5.34
2.4
2.8
nmol/l
3.4
6.8
0.53
18
53
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
523
4785
1.89
5.33
23.2
14.4
mg/l
20.0
24.0
2.82
454
3791
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
315
2572
1.49
5.25
6.5
6.3
umol/l
11.8
11.3
0.16
305
2434
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
19
5.34
5.05
2.4
3.0
u/ml
600.3
831.3
—
10
19
(3002032) Base excess in Venous blood by calculation
77
455
1.80
5.03
3.9
3.8
mmol/l
2.5
2.1
0.40
64
363
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
285
2295
1.47
5.01
5.5
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
500
4533
1.72
5.01
20.0
13.3
ml/min/173m2
81.3
79.8
0.87
448
3729
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
75
442
1.80
4.94
2.4
2.3
u/l
47.0
31.7
0.84
66
372
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
10
9.12
4.80
1.4
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
293
2391
1.45
4.70
4.9
3.7
estimate
0.0
0.0
0.50
50
427
(3000492) Spirometry study
73
434
1.78
4.67
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
43
3.55
4.64
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
289
2358
1.45
4.61
6.5
5.0
estimate
0.0
0.0
0.50
54
443
(3006653) Thiamine [Moles/volume] in Blood
11
25
4.47
4.58
1.1
1.3
nmol/l
121.2
138.0
0.78
11
25
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
363
3101
1.45
4.47
3.9
3.2
u/l
49.8
50.6
0.07
342
2891
(3024928) Oxygen saturation in Venous blood
26
106
2.52
4.44
6.2
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
194
1476
1.47
4.43
3.4
3.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
50
268
1.95
4.42
2.7
3.4
pmol/l
4.2
4.6
1.37
42
241
(3021440) Promyelocytes/100 leukocytes in Blood
64
374
1.80
4.34
5.4
4.3
%
0.4
0.1
0.41
18
114
(3017143) Hepatitis C virus Ab [Presence] in Serum
77
476
1.71
4.31
1.3
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
286
2350
1.43
4.28
4.8
3.7
estimate
0.0
0.0
0.00
52
444
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
13
7.01
4.17
1.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
13
7.01
4.17
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
114
785
1.56
4.15
4.4
2.8
e6/l
5.7
1.8
1.71
70
425
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
75
2.73
4.03
6.9
2.9
e9/l
3.8
4.5
0.71
20
75
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
7
10.10
4.02
1.4
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
130
932
1.51
3.93
1.8
1.7
nmol/l
1046.5
1205.2
1.30
104
702
(3001122) Ferritin [Mass/volume] in Serum or Plasma
255
2079
1.40
3.87
3.5
2.7
ug/l
164.7
137.4
0.55
247
1903
(3017181) Myelocytes/100 leukocytes in Blood
66
403
1.72
3.86
5.3
4.1
%
0.7
0.9
0.23
19
132
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
119
843
1.52
3.80
4.1
2.6
e6/l
1.1
1.1
0.01
75
481
(3051611) Lipemic interference index of Serum or Plasma
14
44
3.24
3.80
4.2
3.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
87
574
1.61
3.79
3.3
2.6
%
1.7
1.8
0.42
73
518
(36660697) Celiac disease serology panel - Serum
59
351
1.76
3.79
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
142
1044
1.48
3.78
10.1
4.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
78
2.62
3.75
7.3
3.4
%
60.5
57.3
0.57
20
78
(3011397) Hemoglobin [Presence] in Urine by Test strip
148
1099
1.46
3.75
4.8
3.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
60
360
1.74
3.74
5.0
4.1
%
0.6
0.4
0.32
12
95
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
12
6.74
3.68
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
160
1213
1.44
3.62
1.8
1.5
nmol/l
19.6
21.1
0.78
143
1012
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
9
7.85
3.56
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
17
63
2.75
3.52
1.1
1.2
u/ml
1.4
1.5
—
5
17
(3025159) Blasts/100 leukocytes in Blood
58
352
1.72
3.48
5.8
4.3
%
0.0
1.0
0.57
14
100
(40768797) Stomach Pathology biopsy report
97
670
1.54
3.47
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
82
2.49
3.42
1.7
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
540
5102
1.78
3.38
19.1
10.6
u/l
27.1
25.7
0.84
532
4911
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
53
2.88
3.38
1.2
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
10
7.07
3.37
1.1
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
59
2.76
3.34
1.2
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
83
559
1.57
3.32
3.0
2.8
umol/l
15.1
8.3
0.75
73
491
(3017732) Neutrophils [#/volume] in Blood
54
326
1.72
3.31
3.5
2.4
e9/l
4.0
4.2
0.32
42
253
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
90
2.38
3.28
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
569
1.56
3.28
2.2
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
7
8.64
3.27
1.2
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
39
3.12
3.10
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
39
3.12
3.10
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
39
3.12
3.10
1.2
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
8
7.56
3.06
1.2
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
45
2.93
3.04
1.2
1.2
nmol/l
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
112
820
1.45
3.01
1.2
1.3
iu/ml
39.5
35.6
0.09
22
254
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
564
1.53
2.99
2.2
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
40
3.04
2.98
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
40
3.04
2.98
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
40
3.04
2.98
1.3
1.2
—
—
—
0
0
(4094501)
26
128
2.08
2.96
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
157
1.96
2.90
2.2
3.2
u/ml
0.3
0.4
0.43
15
86
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
269
1.73
2.88
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
35
194
1.86
2.87
9.9
4.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
209
1.82
2.86
1.9
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
123
2.08
2.85
1.1
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
111
2.12
2.76
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
42
2.90
2.76
1.1
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.39
2.75
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
10
6.05
2.70
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
120
2.04
2.64
2.2
1.7
iu/l
4.9
5.0
—
7
40
(4306422)
14
55
2.58
2.63
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
74
2.34
2.60
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
317
1.63
2.59
1.2
1.2
iu/ml
184.0
156.0
0.12
15
127
(4062490)
11
38
2.93
2.59
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
131
1658
0.73
2.59
2.6
2.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
132
1023
1.38
2.56
1.3
1.2
u/ml
0.7
1.4
2.23
29
281
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
150
1.91
2.56
1.5
1.5
ug/g
263.3
282.5
0.21
18
89
(40767503) Oxygen content in Capillary blood by calculation
21
101
2.12
2.56
3.2
2.4
%
17.3
16.1
0.71
13
52
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
122
934
1.39
2.55
2.3
3.1
mmol/l
2.4
2.5
1.15
103
827
(3022948) Iron [Moles/volume] in Serum or Plasma
105
785
1.41
2.52
2.4
2.5
umol/l
12.5
13.1
0.36
99
725
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
144
1.92
2.50
1.3
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
21
3.85
2.47
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
21
3.85
2.47
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
96
2.12
2.45
6.7
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
188
1548
1.32
2.43
2.9
2.5
u/l
58.8
56.6
0.45
176
1428
(3013512) EKG study
179
1464
1.32
2.43
4.4
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
260
1.66
2.40
1.4
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
17
4.15
2.36
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
71
2.29
2.36
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
160
1295
1.32
2.32
5.3
3.9
estimate
0.0
0.0
0.69
47
429
(40768804) Tissue Pathology biopsy report
229
1947
1.29
2.31
2.3
2.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
23
3.51
2.27
1.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
80
581
1.44
2.25
2.2
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
91
677
1.41
2.25
2.5
2.5
%
22.8
22.7
0.02
79
585
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
54
2.44
2.21
1.2
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
18
87
2.10
2.19
6.9
1.8
%
69.9
62.6
0.79
18
87
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
24
3.36
2.18
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
82
602
1.42
2.18
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
94
2.06
2.18
3.2
2.6
—
—
—
0
0
(4010399)
53
360
1.52
2.09
1.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
56
386
1.50
2.06
3.5
3.1
ng/l
146.2
187.6
0.66
50
351
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
38
240
1.62
2.04
4.4
2.5
%
0.7
0.7
0.14
38
233
(3048689) Calprotectin [Mass/mass] in Stool
75
550
1.42
2.02
1.7
2.3
ug/g
211.5
142.2
0.44
59
436
(3012501) Base excess in Blood by calculation
19
98
1.97
1.97
10.7
3.5
mmol/l
2.4
2.6
0.12
14
64
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
113
1.89
1.94
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
106
1.92
1.93
1.5
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
22
121
1.85
1.91
1.1
1.2
—
55.7
—
0
7
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
59
2.23
1.85
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
521
4989
1.41
1.83
21.4
13.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
12
4.19
1.82
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
53
2.29
1.81
2.0
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
29
2.78
1.79
3.4
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
59
424
1.44
1.79
4.2
2.8
e9/l
63.8
70.2
0.65
43
332
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
407
1.44
1.79
1.9
2.7
ml/min/173m2
83.6
65.1
2.65
21
163
(3012516) Albumin [Mass/volume] in Urine
175
1481
1.26
1.76
2.9
3.3
mg/l
407.2
262.5
0.16
116
951
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
18
3.36
1.75
1.7
1.7
ug/l
44.1
66.6
—
6
18
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
36
2.52
1.74
1.1
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
24
2.94
1.72
1.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
96
1.90
1.72
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
118
1.81
1.72
1.3
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
48
2.32
1.71
1.3
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
42
2.41
1.68
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
31
2.60
1.66
3.3
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
129
1059
1.28
1.66
5.4
4.0
kg/l
1.0
1.0
0.04
19
149
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
25
2.82
1.65
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
181
1550
1.24
1.63
2.9
3.1
mmol/l
8.0
7.6
0.61
157
1282
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
56
2.17
1.62
1.3
1.6
%
27.4
64.0
—
7
42
(3026389) Candida sp identified in Specimen by Organism specific culture
12
56
2.17
1.62
1.6
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
175
1.63
1.61
2.0
2.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
32
2.52
1.60
4.8
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
307
2782
1.22
1.59
3.2
2.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
137
1.71
1.57
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
15
3.35
1.52
1.4
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
5
15
3.35
1.52
1.6
1.1
mmol/l
1.2
2.3
—
5
15
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
37
2.45
1.48
1.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
44
312
1.44
1.46
4.5
3.3
g/l
129.2
127.3
0.24
44
306
(3044927) Protein electrophoresis panel - Urine
12
59
2.06
1.44
2.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
66
1.99
1.44
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
126
1.69
1.42
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
81
1.87
1.41
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
74
1.91
1.40
1.3
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
29
2.43
1.39
1.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
23
2.62
1.37
6.3
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
179
1557
1.22
1.36
3.4
4.0
mg/mmol
9.3
8.8
0.03
112
977
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
75
1.89
1.35
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
75
1.89
1.35
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
258
0.57
1.35
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
68
1.93
1.34
1.9
3.0
—
—
—
0
0
(4024509)
9
42
2.16
1.34
1.7
1.4
—
—
—
0
0
(4035726)
58
440
1.35
1.33
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
67
520
1.33
1.32
1.5
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
421
3973
1.21
1.31
31.0
17.8
%
13.9
13.7
1.57
415
3900
(3003694) ABO and Rh group [Type] in Blood
150
1287
1.22
1.31
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
76
1.86
1.30
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
76
1.86
1.30
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
76
1.86
1.30
1.3
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
71
557
1.31
1.30
1.3
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
545
5304
1.41
1.28
37.9
21.3
e9/l
256.8
246.3
2.98
539
5165
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
84
1.81
1.28
1.4
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
148
1273
1.22
1.26
2.6
2.8
umol/l
17346.8
7242.2
0.80
133
1089
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.5
1.7
—
—
—
0
0
(4211845)
6
25
2.41
1.24
6.5
3.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
8
36
2.24
1.24
1.3
1.2
nmol/l
458.5
377.2
—
8
31
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
45
2.02
1.23
1.1
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
545
5308
1.40
1.23
37.9
21.3
e12/l
4.5
4.5
0.03
539
5151
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
63
1.92
1.23
3.8
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
545
5309
1.40
1.22
37.9
21.3
e9/l
6.9
6.7
0.95
538
5148
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
86
1.76
1.20
1.3
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
117
1.64
1.19
2.0
1.8
u/l
3004.0
5024.9
—
7
36
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
26
2.32
1.19
1.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.5
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
94
775
1.25
1.18
1.2
1.3
u/ml
32.0
11.8
0.68
24
288
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.2
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.2
2.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
225
1.45
1.15
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
328
1.37
1.14
3.0
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
151
1.54
1.13
1.6
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
205
1835
1.18
1.12
5.3
3.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.11
1.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
73
1.80
1.11
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
296
1.38
1.09
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
21
2.39
1.09
1.4
2.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
41
1.96
1.09
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.4
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
67
1.81
1.05
1.4
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
19
122
1.58
1.03
1.6
1.7
e6/l
5589.8
15870.1
1.19
13
90
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
48
1.89
1.01
1.1
1.8
—
—
—
0
0
(4268621)
9
48
1.89
1.01
1.7
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
48
1.89
1.01
1.1
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
48
1.89
1.01
1.1
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
115
1.58
1.00
1.9
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
92
1.65
0.98
1.3
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
382
1.31
0.97
4.0
4.1
ng/l
98.5
83.8
0.34
44
341
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
108
1.59
0.97
1.5
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
36
1.96
0.97
5.0
1.7
%
13.1
11.2
—
7
36
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
27
2.23
0.93
1.8
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
27
2.23
0.93
1.8
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
27
2.23
0.93
1.5
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
76
632
1.23
0.91
25.9
22.8
inr
1.4
1.2
0.26
14
90
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
94
1.61
0.91
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
78
651
1.23
0.90
4.0
4.6
%
30.0
31.7
0.92
59
429
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
466
4492
1.19
0.90
6.1
6.0
mmol/mol
40.2
40.1
0.18
445
4147
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
88
745
1.21
0.89
2.2
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
119
1.53
0.89
1.3
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
433
1.27
0.89
3.5
2.5
ug/l
3.9
6.3
1.26
45
394
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
136
1.49
0.87
2.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
57
1.77
0.84
1.1
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
11
66
1.68
0.79
1.2
1.1
—
16.4
—
0
5
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
34
1.77
0.76
1.3
1.7
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.1
—
52.0
—
0
21
(3044941) Cell count panel - Synovial fluid
12
75
1.61
0.75
1.2
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
24
2.09
0.74
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
133
0.60
0.74
3.3
5.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
40
1.76
0.71
1.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
1048
1.16
0.71
1.8
1.7
pmol/l
400.4
429.6
0.55
106
864
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
143
0.62
0.70
1.3
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
213
1.33
0.70
1.6
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
135
1.42
0.70
1.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
110
1.47
0.69
3.1
4.2
mg/l
44.8
27.9
—
8
69
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
61
1.65
0.69
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
153
1.39
0.68
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
153
1.39
0.68
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
86
748
1.18
0.68
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
93
0.53
0.67
1.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
154
1.38
0.66
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
44
1.60
0.65
1.0
1.2
—
79.0
—
0
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
121
1.42
0.63
1.5
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
51
1.58
0.60
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
359
3441
1.11
0.60
4.1
3.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
72
1.54
0.59
1.4
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
53
1.52
0.58
2.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
35
1.72
0.58
1.5
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
6
35
1.72
0.58
4.5
1.5
—
—
—
0
0
(4146454)
8
54
1.49
0.57
2.3
2.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
185
1.31
0.57
2.5
3.4
g/l
0.1
0.2
1.63
13
75
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.57
1.8
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
69
601
1.17
0.55
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
122
0.65
0.55
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
61
1.48
0.54
5.9
2.1
pg
33.7
33.0
—
9
61
(3028707) Methadone [Presence] in Urine by Screen method
9
61
1.48
0.54
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
59
677
0.86
0.50
1.6
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
41
1.47
0.50
1.3
1.2
u/l
9.3
11.5
—
6
36
(40761535) Cells panel - Urine sediment
50
428
1.18
0.50
5.5
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
136
1.33
0.49
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
195
1828
1.10
0.49
4.5
5.1
ug/l
3.0
2.6
0.20
177
1620
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
61
532
1.16
0.49
4.3
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
163
1.30
0.49
1.1
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
403
1.18
0.47
5.3
3.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
142
0.70
0.46
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
83
0.60
0.46
1.8
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
219
1.24
0.46
5.4
5.4
%
1.5
1.5
0.07
22
207
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
210
1.25
0.46
1.3
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
87
1.39
0.42
2.5
1.7
—
—
—
0
0
(44790049)
8
57
1.41
0.42
1.0
1.5
—
—
—
0
0
(44790048)
8
57
1.41
0.42
1.0
1.5
—
—
—
0
0
(44790047)
8
57
1.41
0.42
1.0
1.5
—
—
—
0
0
(44806118)
8
57
1.41
0.42
1.0
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
1.4
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
58
1.38
0.41
1.9
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
368
0.83
0.41
1.5
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
114
1.32
0.41
1.2
1.3
miu/ml
215.4
243.4
—
5
49
(44806420)
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
480
4711
1.11
0.39
5.1
4.7
mmol/l
5.9
6.0
0.41
456
4278
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
61
1.32
0.39
1.3
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
61
1.32
0.39
1.4
1.3
mmol/l
5.6
6.3
—
8
56
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
366
0.84
0.39
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
89
1.36
0.38
1.7
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
89
1.36
0.38
1.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
107
1.32
0.37
2.3
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
338
1.16
0.36
1.3
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
79
0.63
0.35
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
79
0.63
0.35
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
79
0.63
0.35
1.6
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
79
0.63
0.35
1.6
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
126
0.71
0.35
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
26
218
1.20
0.35
2.5
2.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
26
218
1.20
0.35
5.5
5.4
%
1.0
0.9
1.51
21
204
(3021387) Prolactin [Units/volume] in Serum or Plasma
17
136
1.26
0.34
1.4
1.4
mu/l
248.7
266.9
0.21
17
124
(21494755) Public health laboratory ask at order entry panel
33
381
0.86
0.33
1.3
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
89
0.67
0.33
1.5
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.0
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
52
1.35
0.31
2.9
3.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
22
184
1.20
0.31
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
250
1.17
0.30
2.7
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
364
1.14
0.29
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
136
1286
1.08
0.29
4.6
3.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
64
1.25
0.27
2.1
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
120
0.75
0.27
1.6
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
122
1.24
0.27
3.8
4.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
215
1.17
0.27
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
66
1.22
0.27
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
2.5
2.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
71
0.70
0.26
2.4
2.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
74
0.67
0.26
2.4
2.8
mmol/l
4.0
4.1
—
5
74
(3035285) Chloride [Moles/volume] in Venous blood
5
74
0.67
0.26
2.4
2.8
mmol/l
106.4
105.3
—
5
74
(3003434) Protein [Mass/volume] in Pleural fluid
9
74
1.22
0.25
1.6
1.4
g/l
32.4
32.7
—
9
63
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
137
1306
1.06
0.24
1.6
1.7
mmol/l
1.5
1.4
0.58
117
1086
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.0
—
8.0
—
0
11
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
4.8
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
2.5
—
7292.1
—
0
10
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(4281824)
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
51
1.18
0.19
4.5
2.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.19
1.5
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
67
0.74
0.17
1.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
68
0.73
0.17
1.6
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
68
0.73
0.17
9.8
4.6
umol/l
307.8
370.1
—
5
61
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
68
0.73
0.17
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
70
0.71
0.16
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
101
1.19
0.16
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
244
0.90
0.15
3.0
3.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
469
4730
0.96
0.14
4.5
4.5
mmol/l
1.4
1.5
0.99
437
4320
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
538
0.94
0.12
3.5
4.1
ug/l
26.0
34.6
0.13
42
452
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
109
1060
1.03
0.10
2.7
3.1
ug/l
0.6
0.7
2.06
78
712
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
483
4858
0.97
0.09
5.0
5.1
mmol/l
2.7
2.7
0.21
445
4436
(4034850)
14
155
0.90
0.09
6.7
10.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
453
4560
0.97
0.09
4.1
4.1
mmol/l
1.4
1.3
1.61
423
4152
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
150
1469
1.03
0.09
3.8
4.4
%
22.1
21.0
0.37
73
722
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
56
1.07
0.08
1.7
1.4
u/l
19.3
27.8
—
6
45
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
88
1.14
0.08
1.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
64
1.09
0.08
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
66
1.06
0.08
1.1
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
74
0.81
0.07
1.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
88
1.02
0.07
4.6
3.2
u/ml
404.1
26.1
—
9
88
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
404
1.04
0.06
1.8
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
474
4760
0.98
0.05
4.6
4.6
mmol/l
4.7
4.6
0.32
446
4382
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
139
1.08
0.05
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
130
0.92
0.04
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
130
0.92
0.04
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
51
523
0.97
0.04
1.6
1.8
%
1.5
1.5
0.01
44
452
(3027008) Opiates [Presence] in Urine
12
129
0.93
0.03
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
128
0.94
0.02
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
431
4301
1.01
0.01
28.0
15.6
%
39.6
39.7
0.09
305
2998
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
126
0.95
0.00
1.6
1.6
nmol/l
33.4
41.4
1.12
12
118
(3008898) HLA-B27 [Presence]
16
166
0.96
0.00
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
244
1.03
0.00
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
166
1.02
0.00
1.8
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
122
0.98
0.00
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
63
629
1.00
0.00
12.7
7.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
73
0.96
0.00
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
50
1.00
0.00
2.0
2.4
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
5.0
—
7.0
—
0
6
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
54
0.93
0.00
2.2
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
49
1.02
0.00
1.4
2.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
69
0.87
0.00
1.5
3.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.6
—
0
8
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
52
0.96
0.00
1.2
2.4
umol/l
54.6
4.7
—
5
40
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
51
0.98
0.00
2.4
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
59.0
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint G6_MYASTHENIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MYASTHENIA | 1.455 [1.19, 1.78] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.096 |
During the follow-up period (1.1.1998 — 31.12.2019), 200 out of 993 females with G6_MYASTHENIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MYASTHENIA | 1.196 [1.01, 1.42] | 0.04 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 269 out of 1043 males with G6_MYASTHENIA died.
Mortality risk
Mortality risk for people of age
years, who have G6_MYASTHENIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.116% | 0.157% |
| 5 | 0.643% | 1.359% |
| 10 | 1.895% | 3.372% |
| 15 | 3.606% | 6.583% |
| 20 | 6.362% | 11.147% |
Relationships between endpoints
↥Index endpoint: G6_MYASTHENIA – Myasthenia gravis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data